Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.88 HKD | +1.83% | +5.84% | +13.12% |
03-28 | Aim Vaccine Submits Pre-Applications for Clinical Trials for Two Vaccines; Shares Up 3% | MT |
03-28 | Aim Vaccine's Loss Quadruples in 2023 as Revenue Slips 6%; Shares Up 3% | MT |
Sales 2024 * | 3.41B 471M 3.68B 37.5B | Sales 2025 * | 4.67B 645M 5.04B 51.43B | Capitalization | 9.78B 1.35B 10.56B 108B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.14 x |
Net Debt 2024 * | 904M 125M 976M 9.95B | Net Debt 2025 * | 575M 79.43M 621M 6.33B | EV / Sales 2025 * | 2.22 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,624 |
Yield 2024 * |
1.57% | Yield 2025 * |
2.99% | Free-Float | 22.09% |
1 day | +1.83% | ||
1 week | +5.84% | ||
Current month | +9.23% | ||
1 month | +8.42% | ||
3 months | +30.97% | ||
6 months | -7.02% | ||
Current year | +13.12% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Zhou
CEO | Chief Executive Officer | 58 | 30/04/15 |
Wen Guan
PSD | President | 57 | 30/11/16 |
Li Xin Niu
DFI | Director of Finance/CFO | 52 | 30/09/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ker Wei Pei
BRD | Director/Board Member | 67 | 18/09/20 |
Lun Ma
BRD | Director/Board Member | 62 | 30/11/15 |
Xin Zhou
BRD | Director/Board Member | 55 | 30/04/13 |
Date | Price | Change | Volume |
---|---|---|---|
03/05/24 | 8.88 | +1.83% | 800 |
02/05/24 | 8.72 | +3.32% | 143,200 |
30/04/24 | 8.44 | +0.72% | 193,400 |
29/04/24 | 8.38 | +1.58% | 242,000 |
26/04/24 | 8.25 | +0.86% | 201,800 |
Delayed Quote Hong Kong S.E., May 03, 2024 at 09:09 am
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.12% | 1.35B | |
-3.79% | 87.06B | |
+2.76% | 40.25B | |
-17.49% | 31.09B | |
+54.56% | 24.74B | |
-13.13% | 15.91B | |
-9.12% | 11.96B | |
-15.45% | 11.92B | |
-42.56% | 11.61B | |
+5.09% | 8.73B |
- Stock Market
- Equities
- 6660 Stock